What is NTHI's current stock price?

NTHI (Neonc Technologies Holdings, Inc.) is currently trading at $5.95 with a market cap of $119.0M.

InvestLog

NTHI

Neonc Technologies Holdings, Inc.NASDAQHealthcare

$5.95-2.30%ClosedMarket Cap: $119.0M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-9.68

P/S

2975.00

EV/EBITDA

-2.31

DCF Value

—

FCF Yield

-14.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

54.2%

Operating Margin

-125580.1%

Net Margin

-130777.9%

ROE

471.8%

ROA

-1280.9%

ROIC

439.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 2025	$0.00	$-8.6M	$-0.45
Q2 2025	$0.00	$-5.7M	$-0.30
Q1 2025	$40.0K	$-38.0M	$-2.10

Trading Activity

Insider Trades

View All

Heshmatpour Amir Fdirector, 10 percent owner, officer: President

BuyMon Nov 24

Heshmatpour Amir Fdirector, 10 percent owner, officer: President

BuyMon Nov 24

Heshmatpour Amir Fdirector, 10 percent owner, officer: President

BuyMon Nov 24

CHIANG MING-FU (ALAN)director

SellMon Nov 24

Neman-Ebrahim Youshaofficer: Chief Clinical Officer

BuyMon Nov 24

Company Info

Sector

Healthcare

Industry

—

Country

Exchange

NASDAQ

Beta

2.39

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.